Magnesium: its role in nutrition and carcinogenesis

• Autorzy: Blaszczyk U. , Duda-Chodak A.
• Języki publikacji: EN

Abstrakty

EN

Magnesium (Mg2+) plays a key role in many essential cellular processes such as intermediary metabolism, DNA replication and repair, transporting potassium and calcium ions, cell proliferation together with signalling transduction. Dietary sources rich in magnesium are whole and unrefined grains, seeds, cocoa, nuts, almonds and green leafy vegetables. Hard water is also considered to be an important source of magnesium beneficial to human health. The daily dietary intake of magnesium is however frequently found to be below that recommended in Western countries. Indeed, it is recognised that magnesium deficiency may lead to many disorders of the human body, where for instance magnesium depletion is believed to play an important role in the aetiology of the following; cardiovascular disease (including thrombosis, atherosclerosis, ishaemic heart disease, myocardial infarction, hypertension, arrhythmias and congestive heart failure in human), as well as diabetes mellitus, gastrointestinal (GI) tract disease, liver cirrhosis and diseases of the thyroid and parathyroid glands. Insufficient dietary intake of magnesium may also significantly affect the development and exacerbation of ADHD (Attention Deficit- Hyperactivity Disorder) symptoms in children. The known links between magnesium and carcinogenesis still remain unclear and complex, with conflicting results being reported from many experimental, epidemiological and clinical studies; further knowledge is thus required. Mg2+ ions are enzyme cofactors involved in DNA repair mechanisms that maintain genomic stability and fidelity. Any magnesium deficiencies could thereby cause a dysfunction of these systems to occur leading to DNA mutations. Magnesium deficiency may also be associated with inflammation and increased levels of free radicals where both inflammatory mediators and free radicals so arising could cause oxidative DNA damage and therefore tumour formation. The presented review article now provides a summary discussion of the various research performed concerning the impact that low magnesium intake has on tumour incidence; this includes impairment of magnesium homeostasis frequently observed in tumour cells, the influence of magnesium depletion on the progression of existing tumours and the occurrence of hypo-magnesaemia when patients are treated with certain anticancer drugs.

PL

Magnez odgrywa kluczową rolę w wielu procesach komórkowych, takich jak metabolizm energii, replikacja i naprawa DNA, transport jonów potasu i wapnia, proliferacja komórek, a także transdukcja sygnału. Pełne ziarna zbóż, kakao, orzechy, migdały, zielone warzywa liściaste są dobrym źródłem magnezu. Twarda woda jest również uważana za ważne źródło magnezu, które pozytywnie wpływa na zdrowie człowieka. Dzienne spożycie magnezu w krajach zachodnich często jest poniżej zalecanej dawki. Niedobór magnezu może prowadzić do wielu zaburzeń w organizmie człowieka. Uważa się, że deficytjonów Mg2+ może odgrywać ważną rolę w etiologii wielu chorób, takich jak choroby sercowo-naczyniowe (zakrzepica, miażdżyca tętnic, choroba niedokrwienna serca, zawał mięśnia sercowego, nadciśnienie, zaburzenia rytmu serca, zastoinowa niewydolność serca), cukrzyca, choroby układu pokarmowego, marskość wątroby, choroby tarczycy i przytarczyc. Niewystarczające spożycie magnezu może mieć znaczący wpływ na rozwój i pogłębienie objawów ADHD u dzieci. Rola magnezu w procesie kancerogenezy jest skomplikowana. Mimo stosunkowo dużej liczby badań aktualny stan wiedzy na temat zależności pomiędzy poziomem magnezu, a kancerogenezą jest ciągle niewystarczający i niespójny. Jony magnezu pełnią funkcję kofaktorów enzymów zaangażowanych w mechanizmy naprawcze DNA, które odpowiedzialne są za utrzymywanie stabilności genomu i wierności replikacji. W związku z tym niedobór magnezu może przyczyniać się do wadliwego działania tych systemów i występowania mutacji DNA. Ponadto, w badaniach na zwierzętach obserwowano korelację pomiędzy obniżonym stężeniem magnezu, a stanem zapalnym i wzrostem poziomu wolnych rodników. Zarówno mediatory zapalne jak i wolne rodniki przyczyniają się do generowania uszkodzeń oksydacyjnych DNA, których następstwem może być powstawanie nowotworów. W artykule omówiono niektóre aspekty badań dotyczących wpływu niskiego spożycia magnezu na częstość występowania nowotworów, zaburzonej homeostazy magnezu obserwowanej w komórkach nowotworowych, wpływu niedoboru magnezu na progresję istniejących nowotworów oraz występowania hipomagnezemii w trakcie leczenia pacjentów niektórymi lekami przeciwnowotworowymi.

Słowa kluczowe

EN

magnesium; human nutrition; carcinogenesis; tumour; magnesium deficiency; cellular process; human metabolism; dietary factor; human health; human disease; mortality; cancer

• Wydawca: -
• Czasopismo: Roczniki Państwowego Zakładu Higieny
• Rocznik: 2013
• Tom: 64
• Numer: 3
• Opis fizyczny: p.165-171,ref.

Twórcy

autor

Blaszczyk U.

• Department of Fermentation Technology and Technical Microbiology, Agricultural University in Krakow, Balicka 122, 30-149 Krakow, Poland

autor

Duda-Chodak A.

• Department of Fermentation Technology and Technical Microbiology, Agricultural University in Krakow, Balicka 122, 30-149 Krakow, Poland

Bibliografia

• 1. Anastassopoulou J., Theophanides T.: Magnesium–DNA interactions and the possible relation of magnesium to carcinogenesis. Irradiation and free radicals. Crit Rev Oncol Hematol 2002;42:79-91.
• 2. Anghileri L.: Magnesium, calcium and cancer. Magnes Res 2009;22:247–255.
• 3. Bernardini D., Nasulewicz A., Mazur A., Maier J.A.: Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. Front Biosci 2005;10:1177–1182.
• 4. Bodnar L., Wcislo G., Gasowska-Bodnar A., Synowiec A., Szarlej-Wcisło K., Szczylik C.: Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: A randomised phase II study. Eur J Cancer 2008;44:2604-2614.
• 5. Bois P., Sandborn E.B., Messier P.E.: A study of thymic lymphosarcoma developing in magnesium-deficient rats. Cancer Res 1969;29:763-775.
• 6. Castiglioni S., Maier J.A.M.: Magnesium and cancer: a dangerous liason. Magnes Res 2011;24:S92-S100.
• 7. Chakraborti S., Chakraborti T., Mandal M., Mandal A., Das S., Ghosh S.: Protective role of magnesium in cardiovascular disease: A review. Mol Cell Biochem 2002;238:163-179.
• 8. Chang C.C., Chen C.C., Wu D.C., Yang C.Y.: Nitrate in drinking water and the risk of death from rectal cancer: Does hardness in drinking water matter? J Toxicol Environ Health A 2010;73:1337-1347.
• 9. Chiu H.F., Chang C.C., Yang C.Y.: Magnesium and calcium in drinking water and risk of death from ovarian cancer. Magnes Res 2004;17:28-34.
• 10. Chiu H.F., Tsai S.S., Wu T.N., Yang C.Y.: Colon cancer and content of nitrates and magnesium in drinking water. Magnes Res 2010;23:81-89.
• 11. Chiu H.F., Tsai S.S., Wu T.N., Yang C.Y.: Effect modification of the association between trihalomethanes and pancreatic cancer by drinking water hardness: Evidence from an ecological study. Environ Res 2010;110:513-518.
• 12. Cohen L., Kitzes R:. Early radiation induced proctosigmoiditis responds to magnesium therapy. Magnesium 1985;4:16-19.
• 13. Davis D.: Declining fruit and vegetable nutrient composition: what is the evidence? HortScience 2009;44:15-19.
• 14. Delva P.: Magnesium and coronary heart disease. Mol Aspects Med 2003;24:63-78.
• 15. Doll R., Peto R.: The causes of cancer: quantitative estimates of avoidable risks of cancer in the US today. J Natl Cancer Inst 1981;66:1191-1308.
• 16. Drywień M. E., Nadolna A.: Assessment of mineral bottled water as a sources of selected minerals among students. Rocz Panstw Zakl Hig 2012;63(3):347-352 (in Polish).
• 17. Evans T.R., Harper C.L., Beveridge I.G., Wastnage R., Mansi J.L.: A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil. Eur J Cancer 1995;31A:174-178.
• 18. Folsom A.R., Hong C.P.: Magnesium intake and reduced risk of colon cancer in a prospective study of women. Am J Epidemiol 2006;163:232-235.
• 19. Grzebisz W.: Magnesium – food and human health. J Elementol 2011;16:292-323.
• 20. Hartwig A.: Role of magnesium in genomic stability. Mutat Res 2001;475:113-121.
• 21. Ho C.K., Yang Y.H, Yang C.Y.: Nitrates in drinking water and the risk of death from brain cancer: Does hardness in drinking water matter? J Toxicol Environ Health A 2011;74:747-756.
• 22. Hodgkinson E., Neville-Webbe H.L., Coleman R.E.: Magnesium depletion in patients receiving cisplatinbased chemotherapy. Clin Oncol 2006;18:710-718.
• 23. Jabłecka A., Korzeniowska K., Skołuda A., Cieślewicz A.: Preparations of magnesium. Farm Współ 2011, 4, 29-32 (in Polish).
• 24. Januszko O., Madej D., Postaleniec E., Brzozowska A., Pietruszka B., Kałuża J.: Minerals intake from drinking water by young women. Rocz Panstw Zakl Hig 2012;63(1):43-50 (in Polish).
• 25. Kasprzak K.S., Diwan B.A., Rice J.M.: Iron accelerates while magnesium inhibits nickel-induced carcinogenesis in the rat kidney. Toxicology 1994;90:129-140.
• 26. Kesavan Y., Giovannucci E., Fuchs C.S., Michaud D.S.: A prospective study of magnesium and iron intake and pancreatic cancer in men. Am J Epidemiol 2010;171:233-241.
• 27. Konikowska K., Regulska-Ilow B., Różańska D.: The influence of components of diet on the symptoms of ADHD in children. Rocz Panstw Zakl Hig 2012;63(2):127-134.
• 28. Kuo H. W., Chen P.S., Ho S. C., Wang L. Y., Yang C.Y.: Trihalomethanes in drinking water and the risk of death from rectal cancer: Does hardness in drinking water matter? J Toxicol Environ. Health A 2010;73:807-818.
• 29. Larsson S.C., Bergkvist L., Wolk A.: Magnesium intake in relation to risk of colorectal cancer in women. JAMA 2005;293:86-89.
• 30. Ma E., Sasazuki S., Inoue M., Iwasaki M., Sawada N., Takachi R., Tsugane S.: High dietary intake of magnesium may decrease risk of colorectal cancer in Japanese men. J Nutr 2010;140:779-785.
• 31. Madej D., Kałuża J., Antonik A., Brzozowska A., Roszkowski W.: Calcium, magnesium, iron and zinc in drinking water and status biomarkers of these minerals among elder people from Warsaw region. Rocz Panstw Zakl Hig 2011;62(2):159-168 (in Polish).
• 32. Mahabir S., Forman M.R., Dong Y.Q., Park Y., Hollenbeck A., Schatzkin A.: Mineral intake and lung cancer risk n the NIH-American Association of Retired Persons Diet and Health study. Cancer Epidemiol. Biomarkers Prev 2010;19:1976-1983.
• 33. Mahabir S., Wei Q., Barrera S.L., Dong Y.Q., Etzel C.J., Spitz M.R., Forman M.R.: Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis 2008;29:949-956.
• 34. Maier J.A.M., Nasulewicz-Goldeman A., Simonacci M., Boninsegna A., Mazur A., Wolf F.I.: Insights into the mechanisms involved in magnesium-dependent inhibition of primary tumor growth. Nutr Cancer 2007;59:192-198.
• 35. Michaud D.S., Spiegelman D., Clinton S.K., Rimm E.B., Willett W.C., Giovannucci E.: Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol 2000;152:1145-1153.
• 36. Muallem S., Moe O.W.: When EGF is offside, magnesium is wasted. J Clin Invest 2007;117:2086-2089.
• 37. Nasulewicz A., Wietrzyk J., Wolf F.I., Dzimira S., Madej J., Maier J.A.M, Rayssiguier Y., Mazur A., Opolski A.: Magnesium deficiency inhibits primary tumor growth but favors metastasis in mice. Biochim Biophys Acta 2004;1739:26-32.
• 38. Pasternak K., Kocot J., Horecka A.: Biochemistry of magnesium. J Elementol 2010;15:601-616.
• 39. Patiroğlu T., Şahin G., Kontaş O., Üzüm K., Saraymen R.: Protective effect of magnesium supplementation on experimental 3-methyl cholantrene-induced fibrosarcoma and changes in tissue magnesium distribution during carcinogenesis in rats. Biol Trace Elem Res 1997;56:179- 185.
• 40. Poirier L.A., Theiss J.C., Arnold L.J., Shimkin M.B.: Inhibition by magnesium and calcium acetates of lead subacetate- and nickel acetate-induced lung tumors in strain A mice. Cancer Res 1984;44:1520-1522.
• 41. Rayssiguier Y., Durlach J., Gueux E., Rock E., Mazur A.: Magnesium and ageing. I. Experimental data: Importance of oxidative damage. Magnes Res 1993;6:369-378.
• 42. Romani A.M.P.: Cellular magnesium homeostasis. Arch Biochem Biophys 2011;512:1-23.
• 43. Sahmoun A.E., Singh B.B.: Does a higher ratio of serum calcium to magnesium increase the risk for postmenopausal breast cancer? Med Hypotheses 2010;75:315-318.
• 44. Saris N.E.L., Mervaala E., Karppanen H., Khawaja J.A., Lewenstam A.: Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294:1-26.
• 45. Sartori S., Nielsen I., Tassinari D., Mazzotta D., Vecchiatti G., Sero A., Abbasciano V.: Serum and erythrocyte magnesium concentrations in solid tumors: relationship with stage of malignancy. Magnes Res 1992;5:189-192.
• 46. Smith D.L., Maguire M.E.: Molecular aspects of Mg2+ transport systems. Miner Electrolyte Metab 1993;19:266-276.
• 47. Tanaka T., Shinoda T., Yoshimi N., Niwa K. Iwata H., Mori H.: Inhibitory effect of magnesium hydroxide on methylazoxymethanol acetate-induced large bowel carcinogenesis in male F344 rats. Carcinogenesis 1989;10:613-616.
• 48. Tejpar S., Piessevaux H., Claes K., Piront P., Hoenderop J.G., Verslype C., Van Custem E.: Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study. Lancet Oncol 2007;8:387-394.
• 49. Touyz R.M.: Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 2003;24:107-136.
• 50. Tukiendorf A., Rybak Z.: New data on ecological analysis of possible relationship between magnesium in drinking water and liver cancer. Magnes Res 2004;17:46-52.
• 51. van den Brandt P.A., Smits K.M., Goldbohm R.A., Weijenberg M.P.: Magnesium intake and colorectal cancer risk in the Netherlands Cohort Study. Br J Cancer 2007;96:510-513.
• 52. Vormann J.: Magnesium: nutrition and metabolism. Mol Aspects Med 2003;24:27-37.
• 53. Wang A, Yoshimi N, Tanaka T, Mori H.: Inhibitory effects of magnesium hydroxide on c-myc expression and cell proliferation induced by methylazoxymethanol acetate in rat colon. Cancer Lett 1993;75:73-78.
• 54. Wolf F.I., Cittadini A.: Chemistry and biochemistry of magnesium. Mol Aspects Med 2003;24:3-9.
• 55. Wolf F.I., Cittadini A.R.M., Maier J.A.M.: Magnesium and tumors: Ally or foe? Cancer Treat Rev 2009;35:378-382.
• 56. Wolf F.I., Maier J.A.M., Nasulewicz A., Feillet-Coudray C., Simonacci M., Mazur A., Cittadini A.: Magnesium and neoplasia: From carcinogenesis to tumor growth and progression or treatment. Arch Biochem Biophys 2007;458:24-32.
• 57. Yang C.Y., Chiu H.F., Cheng M.F, Hsu T.Y., Cheng M.F., Wu T.N.: Calcium and magnesium in drinking water and the risk of death from breast cancer. J Toxicol Environ Health A 2000;60:231-241.
• 58. Yang C.Y., Chiu H.F., Cheng M.F., Tsai S.S., Hung C.F., Tseng Y.T.: Pancreatic cancer mortality and total hardness levels in Taiwan’s drinking water. J Toxicol Environ Health A 1999;56:361-369.
• 59. Yang C.Y., Chiu H.F., Chiu J.F., Tsai S.S., Cheng M.F.: Calcium and magnesium in drinking water and risk of death from colon cancer. Jpn J Cancer Res 1997;88:928-933.
• 60. Yang C.Y., Chiu H.F., Tsai S.S., Cheng M.F., Lin M.C., Sung F.C.: Calcium and magnesium in drinking water and risk of death from prostate cancer. J Toxicol Environ Health A 2000;60:17-26.
• 61. Yang C.Y., Chiu H.F., Tsai S.S., Wu T.N., Chang C.C.: Magnesium and calcium in drinking water and the risk of death from esophageal cancer. Magnes Res 2002;15:215-222.
• 62. Yao X., Panichpisal K., Kurtzman N., Nugent K.: Cisplatin nephrotoxicity: a review. Am J Med Sci 2007;334:115-124.